Skip to main content

Edwards Lifesciences Corp Transcatheter Mitral and Tricuspid Therapies revenue

  • EW · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$107.15+1.28%Close 13 Nov 2026 · Market value $61.51B

Transcatheter Mitral and Tricuspid Therapies revenue at Edwards Lifesciences Corp came to $209.5M for the quarter to 30 Sep 2026, up 44.3% from a year earlier.

As Edwards Lifesciences Corp reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$56.0MDec 2023$72.9MMar 2024$83.0MJun 2024$91.1MSep 2024$105.1MDec 2024$115.2MMar 2025$134.5MJun 2025$145.2MSep 2025$155.7MDec 2025$175.1MMar 2026$198.6MJun 2026$209.5MSep 2026
Edwards Lifesciences Corp Transcatheter Mitral and Tricuspid Therapies revenue, every reported period
Period endingTranscatheter Mitral and Tricuspid Therapies revenueChange on a yearFiled
30 Sep 2026$209.5Mup 44.3%4 Nov 2026
30 Jun 2026$198.6Mup 47.7%4 Aug 2026
31 Mar 2026$175.1Mup 52.0%6 May 2026
31 Dec 2025$155.7Mup 48.1%25 Feb 2026
30 Sep 2025$145.2Mup 59.4%5 Nov 2025
30 Jun 2025$134.5Mup 62.0%6 Aug 2025
31 Mar 2025$115.2Mup 58.0%6 May 2025
31 Dec 2024$105.1Mup 87.7%28 Feb 2025
30 Sep 2024$91.1Mup 73.9%6 Nov 2024
30 Jun 2024$83.0Mup 74.4%31 Jul 2024
31 Mar 2024$72.9Mup 75.2%29 Apr 2024
31 Dec 2023$56.0Mup 77.8%12 Feb 2024
30 Sep 2023$52.4Mup 76.4%27 Oct 2023
30 Jun 2023$47.6Mup 70.6%28 Jul 2023
31 Mar 2023$41.6Mup 54.1%28 Apr 2023
31 Dec 2022$31.5Mup 24.5%13 Feb 2023
30 Sep 2022$29.7Mup 33.2%28 Oct 2022
30 Jun 2022$27.9Mup 26.2%29 Jul 2022
31 Mar 2022$27.0Mup 65.6%28 Apr 2022
31 Dec 2021$25.3Mup 93.1%14 Feb 2022
30 Sep 2021$22.3Mup 84.3%29 Oct 2021
30 Jun 2021$22.1Mup 262.3%30 Jul 2021
31 Mar 2021$16.3Mup 55.2%28 Apr 2021
31 Dec 2020$13.1Mup 81.9%12 Feb 2021
30 Sep 2020$12.1Mup 24.7%26 Oct 2020
30 Jun 2020$6.1Mdown 12.9%27 Jul 2020
31 Mar 2020$10.5Mup 144.2%28 Apr 2020
31 Dec 2019$7.2Mup 800.0%14 Feb 2020
30 Sep 2019$9.7Mup 1285.7%25 Oct 2019
30 Jun 2019$7.0Mup 677.8%26 Jul 2019
31 Mar 2019$4.3Mup 760.0%26 Apr 2019
31 Dec 2018$800,000—15 Feb 2019
30 Sep 2018$700,000—26 Oct 2018
30 Jun 2018$900,000—27 Jul 2018
31 Mar 2018$500,000—27 Apr 2018

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Edwards Lifesciences Corp: Transcatheter Aortic Valve Replacement revenue · Surgical revenue · United States revenue · Europe revenue · Rest of World revenue · Japan revenue · financial statements

Every KPI and segment of EW, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.